Clinical Trial Update: Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

A randomized Phase II trial comparing cetuximab with 5-FU plus either cisplatin or carboplatin versus cetuximab with paclitaxel and carboplatin for metastatic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: UNKNOWN